MedTrace Logo

A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants

NCT07679945 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2026-07-01

No results posted yet for this study

Summary

The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.

Conditions

  • Post-inflammatory Hyperpigmentation
  • Melasma
  • Solar Lentigo

Interventions

OTHER

Sunscreen untinted

Participants will apply the facial sunscreen on the face at least twice daily for 56 days

OTHER

Sunscreen tinted

Participants will apply the facial sunscreen on the face at least twice daily for 56 days

Sponsors & Collaborators

  • Kenvue Brands LLC

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-02
Primary Completion
2026-09-25
Completion
2026-09-25

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07679945 on ClinicalTrials.gov